sulforaphane has been researched along with Pulmonary Arterial Hypertension in 1 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Pulmonary Arterial Hypertension: A progressive rare pulmonary disease characterized by high blood pressure in the PULMONARY ARTERY.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We recently demonstrated that sulforaphane (SFN) protected mice from developing pulmonary arterial hypertension (PAH) and right ventricular (RV) dysfunction by elevating cardiac Nrf2 expression and function." | 4.12 | Sulforaphane Does Not Protect Right Ventricular Systolic and Diastolic Functions in Nrf2 Knockout Pulmonary Artery Hypertension Mice. ( Cai, J; Cai, L; Cathey, D; Huang, J; Kang, Y; Keller, BB; LeBlanc, AJ; Wang, S; Zhang, G, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, G | 1 |
| Kang, Y | 1 |
| Cathey, D | 1 |
| LeBlanc, AJ | 1 |
| Cai, J | 1 |
| Cai, L | 1 |
| Wang, S | 1 |
| Huang, J | 1 |
| Keller, BB | 1 |
1 other study available for sulforaphane and Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
Sulforaphane Does Not Protect Right Ventricular Systolic and Diastolic Functions in Nrf2 Knockout Pulmonary Artery Hypertension Mice.
Topics: Animals; Hypertension, Pulmonary; Isothiocyanates; Male; Mice; Mice, Knockout; NF-E2-Related Factor | 2022 |